Supercritical extraction of plant material with carbon dioxide. Scaling up from laboratory to 1/4 technical scale

Na podstawie wyników ekstrakcji nadkrytycznej za pomocą CO2 wykonanej w skali laboratoryjnej dla wsadu wynoszącego ok. 100 g, prowadzonej pod ciśnieniem 20 MPa, wyznaczono najkorzystniejsze temperatury procesu i potwierdzono zasadność dodawania w trakcie procesu rozpuszczalnika organicznego. Uzyskane wyniki wykorzystano przy powiększaniu skali procesu i wykonaniu ekstrakcji wsadu o wadze ok. 5 kg w aparaturze % technicznej pod ciśnieniem 25 MPa. Ekstrakcji poddawano dwa znacznie różniące się surowce roślinne: makuchy lniane i liście zielonej herbaty.Yelocity and yield of the extraction of linseed cake and leafs of green tea with supercritical carbon dioxide were tested. Initially both processes were tested in the laboratory scalę (150 cm3) under pressure of 20 MPa, using a dried and grinded plant feed (90-140 g). The influence of an entrainer was also tested. Optimized conditions such as temperaturę were used in scaling up the extraction. The !/4 scalę process was carried out in the extractor of 10 dm3 volume and under pressure of 25 MPa. Results achieved in the large scalę experiments confirmed conclusions from the laboratory experiments

Studies on the extraction of cyclic peptides from flax waste materials

Cyklopeptydy wydzielono z makuchów i plew lnianych dwiema metodami: ekstrakcją za pomocą nadkrytycznego i ciekłego CO2 oraz tradycyjną ekstrakcją rozpuszczalnikową. Przeprowadzono badania zależności wydajności ekstrakcji cyklopeptydów za pomocą CO2 od temperatury i czasu trwania procesu. Badania wykazały, że wysoka temperatura rozpuszczalników zwiększa zawartość cyklopeptydu CLA w otrzymanych ekstraktach. W przypadku plew lnianych obie zastosowane metody ekstrakcji dały porównywalne wyniki.Cyclopeptides were separated from linseed cakes and chaff using two methods: supercritical and liquid CO2 extraction and traditional solvent extraction. Tests were carried out on the dependencies of cyclopeptide extraction using CO2 on the temperaturę and duration of the process. Studies have shown that high temperaturę of solvents increases the content of cyclopeptide CLA in the obtained extracts. In case of chaff both applied extraction methods have given similar results

Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies

Aims We aimed to evaluate the association between metabolic syndrome (MetS) and long-term all-cause mortality. Methods The LIPIDOGRAM studies were carried out in the primary care in Poland in 2004, 2006 and 2015. MetS was diagnosed based on the National Cholesterol Education Program, Adult Treatment Panel III (NCEP/ATP III) and Joint Interim Statement (JIS) criteria. The cohort was divided into four groups: non-obese patients without MetS, obese patients without MetS, non-obese patients with MetS and obese patients with MetS. Differences in all-cause mortality was analyzed using Kaplan-Meier and Cox regression analyses. Results 45,615 participants were enrolled (mean age 56.3, standard deviation: 11.8 years; 61.7% female). MetS was diagnosed in 14,202 (31%) by NCEP/ATP III criteria, and 17,216 (37.7%) by JIS criteria. Follow-up was available for 44,620 (97.8%, median duration 15.3 years) patients. MetS was associated with increased mortality risk among the obese (hazard ratio, HR: 1.88 [95% CI, 1.79-1.99] and HR: 1.93 [95% CI 1.82-2.04], according to NCEP/ATP III and JIS criteria, respectively) and non-obese individuals (HR: 2.11 [95% CI 1.85-2.40] and 1.7 [95% CI, 1.56-1.85] according to NCEP/ATP III and JIS criteria respectively). Obese patients without MetS had a higher mortality risk than non-obese patients without MetS (HR: 1.16 [95% CI 1.10-1.23] and HR: 1.22 [95%CI 1.15-1.30], respectively in subgroups with NCEP/ATP III and JIS criteria applied). Conclusions MetS is associated with increased all-cause mortality risk in non-obese and obese patients. In patients without MetS obesity remains significantly associated with mortality. The concept of metabolically healthy obesity should be revised